CTOs on the Move

Joerns Healthcare

www.joerns.com

 
Joerns Healthcare is a leading manufacturer and national service provider of patient handling and wound care products to the healthcare continuum. It helps healthcare providers solve complex medical equipment challenges, improve patient and caregiver safety, and speed patient healing with its renowned Purple Shirt service and efficient spend management. Headquartered in Charlotte, North Carolina with 1700 employees throughout North America and Europe, Joerns Healthcare is committed to delivering solutions that improve the lives of patients and care providers.
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.joerns.com
  • 2430 Whitehall Park Drive Suite 100
    Charlotte, NC USA 28273
  • Phone: 800.826.0270

Executives

Name Title Contact Details

Similar Companies

Barrier Technologies

Barrier Technologies is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Imaging Diagnostic Systems

Imaging Diagnostic Systems, Inc. is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tko Surgical

Tko Surgical is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Regional MRI

Regional MRI is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Motif Neurotech

Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.